Solid Biosciences Inc. ( SLDB) - Key Metrics
SLDB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.38 | -$0.37 | -$0.37 |
| 2026Q1 | $0 | -$0.52 | -$0.43 | -$0.43 |
| 2025Q4 | $0 | -$0.53 | -$0.57 | -$0.57 |
| 2025Q3 | $0 | -$0.48 | -$0.35 | -$0.36 |
| 2025Q2 | $0 | -$0.42 | -$0.40 | -$0.40 |
SLDB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.57 |
| 2026Q1 | 0% | -3.46 |
| 2025Q4 | 0% | -2.66 |
| 2025Q3 | 0% | -3.21 |
| 2025Q2 | 0% | -2.90 |
SLDB
Price: $5.53
52 week price:
Earnings Per Share: -1.87 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 27300
Market Capitalization: 674.4 million